+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Insulin-like growth factor binding protein secreted by the human prostate cancer cell line DU145 enhances binding of IGF-1 to its receptor and is regulated by the epidermal growth factor autocrine growth loop



Insulin-like growth factor binding protein secreted by the human prostate cancer cell line DU145 enhances binding of IGF-1 to its receptor and is regulated by the epidermal growth factor autocrine growth loop



Proceedings of the American Association for Cancer Research Annual Meeting 34: 237




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031969576

Download citation: RISBibTeXText


Related references

Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (IGF) binding protein-1: evidence for an IGF-II autocrine growth loop. Journal of Clinical Endocrinology and Metabolism 80(12): 3476-3482, 1995

Insulin-like growth factor binding protein-3 and -5 are regulated by transforming growth factor-beta and retinoic acid in the human prostate adenocarcinoma cell line PC-3. Endocrine 6(3): 235-242, 1997

Insulin-like growth factor-I and epidermal growth factor regulate insulin-like growth factor binding protein-3 (IGFBP-3) in the human keratinocyte cell line HaCaT. Journal of Investigative Dermatology 105(4): 602-607, 1995

Trafficking of nuclear heparin-binding epidermal growth factor-like growth factor into an epidermal growth factor receptor-dependent autocrine loop in response to oxidative stress. Cancer Research 65(18): 8242-8249, 2005

A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-b and insulin-like growth factor binding protein-6, in a calcium- and cell density-dependent manner. The Journal of Biological Chemistry 270: 373-9, 1995

Role of G protein-coupled receptors (GPCR), matrix metalloproteinases 2 and 9 (MMP2 and MMP9), heparin-binding epidermal growth factor-like growth factor (hbEGF), epidermal growth factor receptor (EGFR), erbB2, and insulin-like growth factor 1 receptor (IGF-1R) in trenbolone acetate-stimulated bovine satellite cell proliferation. Journal of Animal Science 93(9): 4291-4301, 2015

A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-beta and insulin-like growth factor binding protein-6, in a calcium- and cell density-dependent manner. Journal of Biological Chemistry 270(21): 12373-9, 1995

Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor-related polypeptides. Prostate 19(2): 173-180, 1991

Autocrine regulation of du145 human prostate cancer cell growth by epidermal growth factor egf related proteins. Proceedings of the American Association for Cancer Research Annual Meeting 32: 43, 1991

Regulation of DUI45 human prostate cancer cell proliferation by insulin-like growth factors and its interaction with the epidermal growth factor autocrine loop. Prostate 24(4): 167-175, 1994

Heparin-binding epidermal growth factor mediates an autocrine loop in a human primary breast cancer cell line. Proceedings of the American Association for Cancer Research Annual Meeting 37: 218, 1996

Heparin-binding epidermal growth factor-like growth factor is an autocrine mediator of human prostate stromal cell growth in vitro. Journal of Urology 165(1): 284-288, 2001

Insulin like growth factor binding protein 3 a possible autocrine growth factor for a human liposarcoma cell line. Clinical Research 38(2): 454A, 1990

Effects of alpha-interferon on insulin-like growth factor-I, insulin-like growth factor-II and insulin-like growth factor binding protein-3 secretion by a human lung cancer cell line in vitro. Journal of Endocrinological Investigation 28(5): 432-439, 2005

Growth factor/growth factor receptor loops in autocrine growth regulation of human prostate cancer DU145 cells. Acta Biochimica Polonica 58(3): 391-396, 2011